Nvidia faces succession questions after calls to retain Huang; the EU and UK may delay EV tariffs, and Alphabet draws $5B in ...

Eli Lilly has secured Chinese regulatory approval for its oral GLP-1 weight-loss drug, orforglipron, becoming the first ...

Nvidia CEO prediction markets put Ian Buck at 35% and Colette Kress at 30%; a report says the board is preparing to remove ...

Stocks and long-dated Treasuries have been moving in tandem more often than they did a decade ago, weakening the ...

Chevron and ExxonMobil both banked a war windfall and have already started giving it back to the shareholders. See why CVX ...

Analyst rates CGI a Buy: ubiquitous systems and customer integration support the view, with entry below $65 delivering ...

Strong market returns can create a difficult trade-off: diversify concentrated holdings and trigger a tax bill, or retain unwanted risk.

Data center moratoriums in New York and Texas have precluded Plug Power from closing important asset sales. Read why PLUG ...

Nu Holdings reported 6.9% of loans at least 90 days past due in Q2 2026, raising surface-level concerns. Learn why NU stock ...

Market Overview A positive third quarter for the price of gold masked considerable intra-period volatility. After a flattish ...

Novo Nordisk's future hinges on broadening its drug franchises, notably CagriSema and Zenagamtide. Read why NVO stock is a ...

PayPal Holdings Inc. delivered good Q3 2026 results, with non-GAAP EPS of $1.45 beating estimates, despite revenue slightly ...